Amedisys, Inc. (NASDAQ:AMED) Shares Sold by California Public Employees Retirement System

California Public Employees Retirement System reduced its stake in shares of Amedisys, Inc. (NASDAQ:AMED) by 5.0% during the 4th quarter, HoldingsChannel reports. The firm owned 58,545 shares of the health services provider’s stock after selling 3,064 shares during the quarter. California Public Employees Retirement System’s holdings in Amedisys were worth $5,565,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Vanguard Group Inc. grew its holdings in Amedisys by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 3,241,160 shares of the health services provider’s stock valued at $302,724,000 after buying an additional 12,137 shares in the last quarter. Pentwater Capital Management LP grew its holdings in shares of Amedisys by 239.5% in the third quarter. Pentwater Capital Management LP now owns 1,144,000 shares of the health services provider’s stock valued at $106,850,000 after purchasing an additional 807,000 shares during the period. Alpine Associates Management Inc. increased its position in Amedisys by 46.6% during the third quarter. Alpine Associates Management Inc. now owns 1,033,497 shares of the health services provider’s stock worth $96,529,000 after purchasing an additional 328,300 shares during the last quarter. Westchester Capital Management LLC raised its stake in Amedisys by 269.7% during the third quarter. Westchester Capital Management LLC now owns 850,386 shares of the health services provider’s stock worth $79,426,000 after purchasing an additional 620,386 shares during the period. Finally, Grantham Mayo Van Otterloo & Co. LLC boosted its holdings in Amedisys by 215.9% in the 3rd quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 314,914 shares of the health services provider’s stock valued at $29,413,000 after purchasing an additional 215,233 shares during the last quarter. 94.36% of the stock is currently owned by hedge funds and other institutional investors.

Amedisys Stock Down 0.4 %

NASDAQ:AMED opened at $92.08 on Friday. Amedisys, Inc. has a 52 week low of $73.10 and a 52 week high of $96.44. The stock’s fifty day moving average is $92.36 and its two-hundred day moving average is $93.32. The stock has a market capitalization of $3.01 billion, a price-to-earnings ratio of -143.87, a price-to-earnings-growth ratio of 3.44 and a beta of 0.84. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.31.

Amedisys (NASDAQ:AMED) last posted its earnings results on Wednesday, April 24th. The health services provider reported $1.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.02 by $0.01. The firm had revenue of $571.41 million for the quarter, compared to analyst estimates of $565.38 million. Amedisys had a positive return on equity of 12.85% and a negative net margin of 0.91%. Amedisys’s revenue was up 2.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.00 EPS. Research analysts anticipate that Amedisys, Inc. will post 4.57 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on AMED shares. StockNews.com upgraded shares of Amedisys from a “hold” rating to a “buy” rating in a report on Saturday. Royal Bank of Canada lifted their target price on Amedisys from $97.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, March 25th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $101.00 price target on shares of Amedisys in a research note on Thursday, April 25th. Finally, Raymond James reissued a “market perform” rating on shares of Amedisys in a research report on Tuesday, March 26th. Seven analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $97.50.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.